Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPART: Dihydroartemisinin-Piperaquine PK in HIV-infected children on ART
NCT04487145Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Nov 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Duocotexin in malaria, sponsored by University of California, San Francisco. Started Nov 2020; status: completed.
02
Drugs
Duocotexin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04487145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04487145.